Bio-Rad Laboratories, Inc. (BIO)
303.06
-1.45
(-0.48%)
USD |
NYSE |
Dec 31, 14:01
Bio-Rad Laboratories EPS Diluted (Quarterly): -12.70 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bruker Corp. | -0.4111 |
| Azenta, Inc. | 1.106 |
| Harvard Bioscience, Inc. | -0.0276 |
| Bionano Genomics, Inc. | -1.593 |
| Kestra Medical Technologies Ltd. | -0.6381 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -341.90M |
| Revenue (Quarterly) | 653.00M |
| Total Expenses (Quarterly) | 994.90M |
| Enterprise Value | 8.189B |
| Gross Profit Margin (Quarterly) | 52.50% |
| Profit Margin (Quarterly) | -52.36% |
| Earnings Yield | -8.02% |
| Operating Earnings Yield | 3.45% |
| Normalized Earnings Yield | 1.720 |